000 | 01485 a2200421 4500 | ||
---|---|---|---|
005 | 20250515064204.0 | ||
264 | 0 | _c20070613 | |
008 | 200706s 0 0 eng d | ||
022 | _a1352-4585 | ||
024 | 7 |
_a10.1177/1352458506071172 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aDi Rezze, S | |
245 | 0 | 0 |
_aAn exploratory study on interferon beta dose effect in reducing size of enhancing lesions in multiple sclerosis. _h[electronic resource] |
260 |
_bMultiple sclerosis (Houndmills, Basingstoke, England) _cApr 2007 |
||
300 |
_a343-7 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Randomized Controlled Trial | ||
650 | 0 | 4 |
_aAdjuvants, Immunologic _xtherapeutic use |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAge of Onset |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInjections, Subcutaneous |
650 | 0 | 4 | _aInterferon beta-1a |
650 | 0 | 4 |
_aInterferon-beta _xadministration & dosage |
650 | 0 | 4 | _aMagnetic Resonance Imaging |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMultiple Sclerosis _xdrug therapy |
650 | 0 | 4 | _aTime Factors |
700 | 1 | _aGupta, S | |
700 | 1 | _aDurastanti, V | |
700 | 1 | _aMillefiorini, E | |
700 | 1 | _aPozzilli, C | |
700 | 1 | _aBagnato, F | |
773 | 0 |
_tMultiple sclerosis (Houndmills, Basingstoke, England) _gvol. 13 _gno. 3 _gp. 343-7 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1177/1352458506071172 _zAvailable from publisher's website |
999 |
_c16990151 _d16990151 |